Home What is the best treatment target in axial spondyloarthritis: tumour necrosis factor alpha, interleukin 17, or both?
|

What is the best treatment target in axial spondyloarthritis: tumour necrosis factor alpha, interleukin 17, or both?

Print
Share
Sign up for the
DRFZ NewsFlash